Holen Sie sich die Stockscreener-App
2.56
4.12%
-0.11
Handel nachbörslich:
2.55
-0.01
-0.39%
Finanzdaten der Galectin Therapeutics Inc-Aktie (GALT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
9.23%
4.198
|
4.625 | 7.897 | 12.43 | 9.066 |
| Operating Income/Loss |
9.23%
-4.198
|
-4.625 | -7.897 | -12.43 | -9.066 |
| Nonoperating Income/Loss |
37.64%
-3.986
|
-2.896 | -1.734 | 0.461 | -2.154 |
| Income/Loss From Continuing Operations Before Tax |
8.82%
-8.184
|
-7.521 | -9.631 | -11.97 | -11.22 |
| Income/Loss From Continuing Operations After Tax |
8.82%
-8.184
|
-7.521 | -9.631 | -11.97 | -11.22 |
|
Net Income/Loss
|
8.82%
-8.184
|
-7.521 | -9.631 | -11.97 | -11.22 |
| Preferred Stock Dividends And Other Adjustments |
38.10%
0.039
|
0.063 | -0.026 | 0.063 | 0.018 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.19%
64.20
|
63.45 | 63.20 | 0.146 | 62.28 |
| Diluted Average Shares |
1.19%
64.20
|
63.45 | 63.20 | 0.146 | 62.28 |
| Basic Earnings Per Share |
8.33%
-0.13
|
-0.12 | -0.15 | -0.19 | -0.18 |
| Diluted Earnings Per Share |
8.33%
-0.13
|
-0.12 | -0.15 | -0.19 | -0.18 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
38.10%
0.039
|
0.063 | -0.026 | 0.063 | 0.018 |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):